Featuring researchers’ fears surrounding clinical trial registries, a roundup of the events planned for Open Access Week 2019 and the release of the Open Pharma Charter
Featuring the upcoming MedComms Brunch Meeting on open access, an investigation into the future of open access publishing, news from the third Asia Pacific Meeting of ISMPP and the scientific community’s toxic definition of success
Featuring the Open Pharma and Pint of Science crossover event, a new pilot project to facilitate the transparent review of preprints and the results from a Nature poll on coercive citations
Featuring the growing traction of Registered Reports, an investigation into the inconsistent role of a peer reviewer, unusual citation patterns in some manuscripts and a new Plan S toolkit
Featuring the pros and cons of ‘patient-orientated research’, a new addition to the Medical Publishing and Insights Practices (MPIP) open access toolkit and an update on Plan S.
Featuring concerns over financing ‘pay to publish’ models, a fresh demand for clinical trial transparency sanctions, and how one highly cited article may influence a journal’s impact factor and a researcher’s career progression.
Featuring the growing need for communication during each stage of the research process, the role of patient experts in a healthcare setting, the association of medical writing support with the quality of clinical trial reporting, and the replacement of supplementary material with online repositories.
Featuring a patient’s perspective on the Health Research Authority’s transparency consultation, the launch of the Journal of Trial and Error and the call for ResearchGate to educate users on responsible content sharing.
Featuring the use of ‘spin’ in clinical trial abstracts, the first publication in UCL Open: Environment, a new clinical trial educational resource and insights from the OASPA webinar on learned societies and open access.
Featuring the release of the AMWA-EMWA-ISMPP position statement on predatory publishing, the hidden disclosures of medical journal editors, the citation advantage of preprints and the launch of the Open Pharma Calendar of Open Access Events